Management of metastatic renal cell carcinoma in the era of targeted therapies
Background: Metastatic renal cell cancer is associated with poor prognosis and survival and is resistant to conventional chemotherapy. Therapeutic targeting of molecular pathways for tumour angiogenesis and other specific activation mechanisms offers improved tumour response and prolonged survival. Aims: To conduct a retrospective audit of metastatic renal cell carcinoma patients treated with targeted therapies. Methods: Data were extracted from clinical records of patients undergoing targeted...[Show more]
|Collections||ANU Research Publications|
|Source:||Internal Medicine Journal|
|01_Webber_Management_of_metastatic_renal_2011.pdf||128.05 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.